The PE Ratio as of December 2025 (TTM) for Anbio Biotechnology Class A Ordinary Shares (NNNN) is 680.50

According to Anbio Biotechnology Class A Ordinary Shares’s latest financial reports and current stock price. The company's current PE Ratio is 680.50. This represents a change of 3.15% compared to the average of 20.93 of the last 4 quarters.

Anbio Biotechnology Class A Ordinary Shares (NNNN) Historical PE Ratio (quarterly & annually)

How has NNNN PE Ratio performed in the past?

The mean historical PE Ratio of Anbio Biotechnology Class A Ordinary Shares over the last ten years is 195.43. The current 680.50 PE Ratio has changed 34.72% with respect to the historical average. Over the past ten years (40 quarters), NNNN's PE Ratio was at its highest in in the December 2023 quarter at 76.94. The PE Ratio was at its lowest in in the December 2024 quarter at -46.05.

Anbio Biotechnology Class A Ordinary Shares (NNNN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Anbio Biotechnology Class A Ordinary Shares PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Anbio Biotechnology Class A Ordinary Shares (NNNN) Average PE Ratio

How has NNNN PE Ratio performed in the past?

The current PE Ratio of Anbio Biotechnology Class A Ordinary Shares (NNNN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Anbio Biotechnology Class A Ordinary Shares (NNNN) PE Ratio vs. Peers

How is NNNN’s PE Ratio compared to its peers?

Anbio Biotechnology Class A Ordinary Shares’s PE Ratio is greater than AngioDynamics, Inc. (-17.47), greater than Talkspace, Inc. (125.86), greater than ClearPoint Neuro, Inc. (-17.88), greater than Community Health Systems, Inc. (1.47), greater than COMPASS Pathways plc (-2.28), greater than Avanos Medical, Inc. (-1.10), greater than KalVista Pharmaceuticals, Inc. (-4.32), greater than Gossamer Bio, Inc. (-5.44), greater than Rigel Pharmaceuticals, Inc. (7.54), greater than SNDL Inc. (-7.08),

Build a custom stock screener for Anbio Biotechnology Class A Ordinary Shares (NNNN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anbio Biotechnology Class A Ordinary Shares using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anbio Biotechnology Class A Ordinary Shares (NNNN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anbio Biotechnology Class A Ordinary Shares or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.